| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$100,566,667 |
|
|
|
Indirect Value
|
$7,138,909 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$107,705,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
159 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-09-04 |
4 |
OE |
$17.50 |
$2,449,650 |
D/D |
140,000 |
399,007 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-10-03 |
4 |
OE |
$17.50 |
$1,224,825 |
D/D |
70,000 |
329,007 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-11-02 |
4 |
OE |
$17.50 |
$1,224,825 |
D/D |
70,000 |
340,187 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-08-01 |
4 |
OE |
$20.74 |
$1,451,800 |
D/D |
70,000 |
1,128,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-09-06 |
4 |
OE |
$20.74 |
$1,451,800 |
D/D |
70,000 |
1,128,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-23 |
4 |
OE |
$21.58 |
$2,157,500 |
D/D |
100,000 |
1,165,924 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-11-13 |
4 |
OE |
$21.58 |
$4,746,500 |
D/D |
220,000 |
1,385,924 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2014-02-14 |
4 |
A |
$21.94 |
$21,243 |
D/D |
968 |
862,016 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2020-12-15 |
4 |
B |
$23.00 |
$2,300,000 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-11-27 |
4 |
OE |
$23.60 |
$6,608,000 |
D/D |
280,000 |
1,574,306 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-05-04 |
4 |
OE |
$27.07 |
$2,165,600 |
D/D |
80,000 |
1,294,306 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-06-29 |
4 |
A |
$29.02 |
$21,271 |
D/D |
733 |
259,007 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2003-06-30 |
4 |
A |
$29.66 |
$19,188 |
D/D |
647 |
43,365 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-10-27 |
4 |
S |
$34.50 |
$759,005 |
D/D |
(22,000) |
89,596 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-02-25 |
4 |
S |
$35.28 |
$705,675 |
D/D |
(20,000) |
92,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-04-29 |
4 |
S |
$36.22 |
$1,087,751 |
D/D |
(30,000) |
92,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2007-09-04 |
4 |
AS |
$36.46 |
$2,203,575 |
D/D |
(60,000) |
207,393 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4 |
D |
$39.79 |
$417,477 |
D/D |
(10,492) |
204,284 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4/A |
D |
$39.79 |
$501,434 |
D/D |
(12,602) |
206,674 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-06-01 |
4 |
S |
$42.83 |
$2,571,336 |
D/D |
(60,000) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2008-12-01 |
4 |
S |
$43.73 |
$2,623,800 |
D/D |
(60,000) |
221,489 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2008-12-01 |
4/A |
S |
$43.73 |
$2,623,800 |
D/D |
(60,000) |
222,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-07-22 |
4 |
S |
$43.97 |
$1,319,605 |
D/D |
(30,000) |
93,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-03-12 |
4 |
D |
$44.04 |
$282,120 |
D/D |
(6,406) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-06 |
4 |
S |
$44.09 |
$4,508,043 |
D/D |
(102,248) |
249,875 |
0 |
- |
|
159 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
